Whole genome sequencing of MRSA from a hospital in Asia has demonstrated patterns of transmission in a resource-limited setting, where formal screening procedures are not feasible.
An experimental drug currently being trialled for influenza and Ebola viruses could have a new target: norovirus, often known as the winter vomiting virus. A team of researchers at the University of Cambridge has shown that the drug, favipiravir, is effective at reducing – and in some cases eliminating – norovirus infection in mice.
Miniature scaffolds made from collagen – the ‘glue’ that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair the heart after a heart attack.
New research reveals how bacteria construct tiny flagella ‘nanomachines’ outside the cell.
Scientists find mutant protein blocks HIV infection and transmission.
Mutations might play a key role in the death of brain cells.
Research could lead to new drugs to turn ‘switch’ off.
Centre will support researchers working in public health and tropical medicine.
New research is helping to unveil how the parasite that causes sleeping sickness uses stealth tactics to escape detection by the human immune system.
A newly designated Collaborating Centre at the University of Cambridge will support the World Health Organization (WHO) in detecting and responding to major epidemic- and pandemic-prone diseases.
© 2025 University of Cambridge